1999
DOI: 10.1007/s001340050989
|View full text |Cite
|
Sign up to set email alerts
|

Whole body hyperthermia: a secure procedure for patients with various malignancies?

Abstract: sCMT, including whole body hyperthermia, accompanied by suitable anesthesiological management and monitoring, does not lead to any serious or sustained organ dysfunction and can therefore be regarded as a safe therapy.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
31
0
1

Year Published

1999
1999
2013
2013

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 37 publications
(34 citation statements)
references
References 15 publications
2
31
0
1
Order By: Relevance
“…Therapeutic whole body hyperthermia (WBH) with body core temperatures up to 42.2°C, which is used for the treatment of patients with disseminated malignancies, has been demonstrated to be feasible with acceptable toxicity when radiant heat devices are employed Hildebrandt et al 2005;Kerner et al 1999;Wust et al 2002). In contrast to the locoregional hyperthermia approaches, its clinical efficacy has not been proven in the scope of randomised trials yet.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Therapeutic whole body hyperthermia (WBH) with body core temperatures up to 42.2°C, which is used for the treatment of patients with disseminated malignancies, has been demonstrated to be feasible with acceptable toxicity when radiant heat devices are employed Hildebrandt et al 2005;Kerner et al 1999;Wust et al 2002). In contrast to the locoregional hyperthermia approaches, its clinical efficacy has not been proven in the scope of randomised trials yet.…”
Section: Introductionmentioning
confidence: 99%
“…Application of therapeutic WBH is associated with extreme acute stress reactions, indicated by significant increase of heart rate, cardiac output and oxygen consumption (Berry et al 1997;Faithfull et al 1984;Kerner et al 1999). In addition, elevated plasma levels of stress hormones have been observed under hyperthermic conditions (Kappel et al 1991;Kearns et al 1999;Robins et al 1987) and suppressive effects of these stress hormones on lymphocyte subpopulations as well as associated cytokines are well known (Elenkov and Chrousos 2002;Iwakabe et al 1998;Kohm and Sanders 2001;Madden et al 1995).…”
Section: Introductionmentioning
confidence: 99%
“…Furthermore, some chemotherapeutic agents are cardiotoxic and WBH can have adverse effects on the cardiopulmonary system [3][4][5][6]. Therefore, intensive monitoring during this procedure is required in order to detect and treat hemodynamic complications as soon as possible.…”
Section: Introductionmentioning
confidence: 99%
“…The whole body hyperthermia technique that raises core body temperature to 399 C, even to 429 C, has also been successfully introduced in clinics. 7,8,11,15) The duration of vecuronium bromide in the case of intra-abdominal high temperature thermal therapy is obviously shortened compared to non-thermal therapy (shortened from 46.2 min to 28.2 min). 1) Thus, iMR imaging could trigger a rise in core body temperature and shorten the duration of clinical action and recovery index of the vecuronium bromide.…”
Section: Discussionmentioning
confidence: 99%